(Total Views: 136)
Posted On: 02/09/2017 4:20:34 PM
Post# of 72443
They didn't spend much for the Bril trials:
"Additional reporting of results from the Phase 2 P-o-C clinical trial of Brilacidin-UP/UPS is anticipated over the coming months, as is an interim analysis in the first half of 2017 of the Phase 2 clinical trial of Brilacidin-OM. Cellceutix’s expenditures on Brilacidin were approximately $0.1 million and $0.8 million during the three months and six months ended December 31, 2016, respectively. "
"Additional reporting of results from the Phase 2 P-o-C clinical trial of Brilacidin-UP/UPS is anticipated over the coming months, as is an interim analysis in the first half of 2017 of the Phase 2 clinical trial of Brilacidin-OM. Cellceutix’s expenditures on Brilacidin were approximately $0.1 million and $0.8 million during the three months and six months ended December 31, 2016, respectively. "
(1)
(0)Scroll down for more posts ▼
